Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.45 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.45 |
| ▸ | DGKA | P23743 | 1/20 | 0.41 |
| ▸ | KDM5A | P29375 | 3/20 | 0.41 |
| ▸ | PHF8 | Q9UPP1 | 3/20 | 0.41 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7787364 | 1.00 | KDM4E (0.47) | KDM4EDUSP3MEN1KMT2ALMNA | |
| SCHEMBL3837641 | 1.00 | KDM4E (0.47) | KDM4EDUSP3MEN1KMT2ALMNA | |
| SCHEMBL2495445 | 1.00 | KDM4E (0.47) | KDM4EDUSP3MEN1KMT2ALMNA | |
| SCHEMBL13936677 | 1.00 | KDM4E (0.47) | KDM4EDUSP3MEN1KMT2ALMNA | |
| SCHEMBL8984841 | 1.00 | KDM4E (0.47) | KDM4EDUSP3MEN1KMT2ALMNA | |
| SCHEMBL7786142 | 1.00 | KDM4E (0.47) | KDM4EDUSP3MEN1KMT2ALMNA | |
| SCHEMBL7786496 | 1.00 | KDM4E (0.47) | KDM4EDUSP3MEN1KMT2ALMNA | |
| SCHEMBL3834662 | 1.00 | KDM4E (0.47) | KDM4EDUSP3MEN1KMT2ALMNA | |
| SCHEMBL2639306 | 0.94 | KDM4E (0.42) | KDM4EDUSP3MEN1KMT2ALMNA | |
| SCHEMBL2496998 | 0.94 | KDM4E (0.44) | KDM4EDUSP3MEN1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230240948-A1 | METHOD FOR PRODUCING COATING | KAO CORPORATION (JP) | 2023-08-03 | — | — | US | disclosed |
| US-20230240948-A1 | METHOD FOR PRODUCING COATING | KAO CORPORATION (JP) | 2023-08-03 | — | — | US | disclosed |
| US-20220031582-A1 | OIL-IN-WATER TYPE SUNSCREEN COSMETIC | KAO CORPORATION (JP) | 2022-02-03 | — | — | US | disclosed |
| EP-3733160-A1 | EMULSIFIED COMPOSITION | Kao Corporation (JP) | 2020-11-04 | — | — | EP | disclosed |
| US-20200337953-A1 | EMULSIFIED COMPOSITION | KAO CORPORATION (JP) | 2020-10-29 | — | — | US | disclosed |
| EP-2662071-B1 | COSMETIC comprising a ceramide | KAO CORP (JP) | 2018-06-20 | — | — | EP | disclosed |
| US-9339448-B2 | Emulsion composition | KAO CORPORATION (JP) | 2016-05-17 | — | — | US | disclosed |
| US-9339448-B2 | Emulsion composition | KAO CORPORATION (JP) | 2016-05-17 | — | — | US | disclosed |
| US-9278059-B2 | Emulsified cosmetic composition | KAO CORPORATION (JP) | 2016-03-08 | — | — | US | disclosed |
| US-9278059-B2 | Emulsified cosmetic composition | KAO CORPORATION (JP) | 2016-03-08 | — | — | US | disclosed |
| US-8178584-B2 | Sphingosines, fatty acid, and oil; improved stability and feel to skin | KAO CORPORATION (JP) | 2012-05-15 | — | — | US | disclosed |
| US-8178584-B2 | Sphingosines, fatty acid, and oil; improved stability and feel to skin | KAO CORPORATION (JP) | 2012-05-15 | — | — | US | disclosed |
| US-20120108661-A1 | EMULSIFIED COMPOSITION | KAO CORPORATION (JP) | 2012-05-03 | — | — | US | disclosed |
| US-20120108661-A1 | EMULSIFIED COMPOSITION | KAO CORPORATION (JP) | 2012-05-03 | — | — | US | disclosed |
| US-20110263714-A1 | Reverse Vesicle | KAO CORPORATION (JP) | 2011-10-27 | — | — | US | disclosed |
| US-20110263714-A1 | Reverse Vesicle | KAO CORPORATION (JP) | 2011-10-27 | — | — | US | disclosed |
| US-6251878-B1 | TREATING ULTRAVIOLET LIGHT-INDUCED SUPPRESSION OF IMMUNE RESPONSE OF SKIN OF ANIMAL BY CONTACTING SKIN WITH COMPOSITION COMPRISING TAMARIND SEED XYLOGLUCAN OLIGOSACCHARIDES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2001-06-26 | — | — | US | disclosed |
| US-5653970-A | CLEANING COMPOUNDS; COSMETICS | LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) | 1997-08-05 | — | — | US | disclosed |
| US-5476671-A | Skin disorders | CHESEBROUGH-POND'S USA CO., DIVISION OF CONOPCO, INC. (US) | 1995-12-19 | — | — | US | disclosed |
| WO-1995016665-A1 | SYNTHETIC CERAMIDES AND THEIR USE IN COSMETIC COMPOSITIONS | UNILEVER PLC (GB) | 1995-06-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220031582-A1 | OIL-IN-WATER TYPE SUNSCREEN COSMETIC | SUN2, H1-0, CUTA | KDM4E 4693/4885DUSP3 4837/4885MEN1 517/4885 |
| US-20230240948-A1 | METHOD FOR PRODUCING COATING | CUTA, KRT18, S100B | KDM4E 250/4885DUSP3 4800/4885MEN1 2776/4885 |
| US-20200337953-A1 | EMULSIFIED COMPOSITION | SGMS2, SGMS1, CERT1 | KDM4E 4176/4885DUSP3 4737/4885MEN1 2457/4885 |
| US-20120108661-A1 | EMULSIFIED COMPOSITION | CERT1, S1PR4, S1PR3 | KDM4E 946/4885DUSP3 4029/4885MEN1 1285/4885 |
| US-20110263714-A1 | Reverse Vesicle | SGMS1, EXOSC10, SGMS2 | KDM4E 1070/4885DUSP3 4696/4885MEN1 2024/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.